Opportunity Information: Apply for CDC RFA GH16 1680

The grant opportunity titled "Reinforcing Capacity at Two Centers of Excellence to Sustain the Delivery of Comprehensive HIV Clinical Services in Haiti under PEPFAR" (Funding Opportunity Number CDC RFA GH16-1680) is a CDC cooperative agreement designed to strengthen and sustain HIV and tuberculosis service delivery in Port-au-Prince, Haiti. The core aim is to support two Centers of Excellence, INLR and IMIS, so they can continue delivering high-quality, comprehensive clinical services for people affected by HIV while also functioning as national reference centers for tuberculosis (TB) and multidrug-resistant TB (MDR TB). The award structure is a cooperative agreement, meaning CDC would typically maintain substantial involvement in program direction, monitoring, and technical support as the work is carried out.

Programmatically, the opportunity focuses on keeping essential prevention, testing, and treatment services operating at a high standard. This includes high-quality HIV testing and counseling (HTC) so that more people can learn their status promptly and be linked to care. It also emphasizes prevention of mother-to-child transmission (PMTCT), reflecting the goal of reducing new pediatric HIV infections by ensuring pregnant and breastfeeding individuals have access to testing, antiretroviral therapy, and follow-up services. In addition, the FOA prioritizes strong pediatric and adult HIV care and treatment services, which generally means maintaining clinical capacity for antiretroviral initiation and management, routine monitoring, adherence support, and management of opportunistic infections. Alongside HIV services, it places major emphasis on TB and MDR TB prevention, diagnosis, and treatment, reinforcing the reality that TB remains a leading cause of illness and death among people living with HIV and that MDR TB requires specialized diagnostic and treatment capacity. By positioning INLR and IMIS as national reference centers for TB and MDR TB, the program is also about strengthening higher-level diagnostic and clinical leadership that can support broader national systems beyond a single facility.

A key administrative point is that the text provided reflects an amendment that is informational only. CDC is not accepting new applications for award under this notice, and the amendment is meant to add or clarify language, specifically around HIV epidemic control under the section described as "Other National Public Health Priorities and Strategies." In practical terms, this signals alignment with the broader PEPFAR direction of driving toward epidemic control by improving diagnosis coverage, treatment coverage, and viral suppression, and by focusing resources and strategies to reduce new infections and HIV-related mortality. Even though no new applications are being accepted, the update indicates how the program is framed in terms of current public health priorities and the language used to describe its strategic intent.

The opportunity is categorized as discretionary funding, falls under the Health activity category, and is associated with CFDA number 93.067. The listing indicates an award ceiling of $3,000,000 and an expectation of one award, suggesting a single primary recipient would have been selected to implement or coordinate the work in close collaboration with CDC and local partners. The original closing date was February 4, 2016, and the opportunity was created on December 4, 2015, which helps place it in the PEPFAR program context of that period.

Eligibility, as described, is extremely broad and includes many types of domestic and non-domestic entities. Eligible applicants include various levels of government (state, county, city/township, special districts, regional organizations, and US territories), educational institutions (public and private institutions of higher education, as well as minority-serving institutions such as HBCUs, Hispanic-serving institutions, and Alaska Native and Native Hawaiian-serving institutions), tribal governments and tribally designated organizations, public housing authorities, nonprofits with or without 501(c)(3) status, individuals, for-profit organizations (including small businesses), and non-US entities. The "Other" eligibility language also explicitly mentions ministries of health, tribal epidemiology centers, urban Indian health organizations, research institutions conducting activities deemed non-research, colleges and universities, community-based and faith-based organizations, hospitals, and small, minority-, and women-owned businesses, followed by a catch-all statement indicating all other eligible organizations. This wide eligibility range is typical of public health FOAs where implementation could plausibly be led by governmental, academic, clinical, or nonprofit actors, especially in international settings where partnerships and local presence can be decisive.

Taken together, this FOA is best understood as a targeted PEPFAR-supported effort to preserve and reinforce high-impact HIV and TB clinical capacity at two key institutions in Port-au-Prince. Its service package combines HIV testing and PMTCT with adult and pediatric treatment, while simultaneously strengthening TB and MDR TB prevention and clinical management, with an added systems role as national reference centers. The amendment does not reopen the competition; it mainly updates the framing to reflect HIV epidemic control priorities within the broader national public health strategy context.

  • The Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Reinforcing Capacity at Two Centers of Excellence to Sustain the Delivery of Comprehensive HIV Clinical Services in Haiti under the President’s Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
  • This funding opportunity was created on 2015-12-04.
  • Applicants must submit their applications by 2016-02-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others.
Apply for CDC RFA GH16 1680

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

1. What is the title of this grant opportunity?

The opportunity is titled "Reinforcing Capacity at Two Centers of Excellence to Sustain the Delivery of Comprehensive HIV Clinical Services in Haiti under PEPFAR."

2. What is the Funding Opportunity Number (FOA number)?

The Funding Opportunity Number is CDC RFA GH16-1680.

3. What type of funding mechanism is this?

This is a CDC cooperative agreement. Under a cooperative agreement, CDC typically has substantial involvement in the program, which can include participation in program direction, ongoing monitoring, and providing technical support during implementation.

4. What is the overall purpose of the opportunity?

The core aim is to strengthen and sustain HIV and tuberculosis (TB) service delivery in Port-au-Prince, Haiti by supporting two Centers of Excellence (INLR and IMIS) so they can continue providing high-quality, comprehensive HIV clinical services and serve as national reference centers for TB and multidrug-resistant TB (MDR TB).

5. Where is the program intended to operate?

The work is focused on Port-au-Prince, Haiti, with a specific emphasis on reinforcing capacity at two Centers of Excellence: INLR and IMIS.

6. Which institutions are identified as the Centers of Excellence?

The two Centers of Excellence referenced are INLR and IMIS.

7. What does it mean that INLR and IMIS will function as national reference centers for TB and MDR TB?

Based on the description provided, the opportunity positions INLR and IMIS to serve a higher-level national role for TB and MDR TB. This includes strengthening specialized diagnostic and treatment capacity and providing clinical and diagnostic leadership that can support broader national systems beyond a single facility.

8. What HIV services are emphasized in the program description?

The opportunity emphasizes maintaining essential prevention, testing, and treatment services at a high standard. Specifically mentioned HIV-related service areas include:

  • High-quality HIV testing and counseling (HTC) to help more people learn their status promptly and be linked to care
  • Prevention of mother-to-child transmission (PMTCT), including testing and access to antiretroviral therapy and follow-up for pregnant and breastfeeding individuals
  • Pediatric and adult HIV care and treatment services, including clinical capacity for antiretroviral initiation and management, routine monitoring, adherence support, and management of opportunistic infections

9. What TB-related services are emphasized?

The opportunity places major emphasis on TB and MDR TB prevention, diagnosis, and treatment. This reflects the public health reality that TB is a leading cause of illness and death among people living with HIV and that MDR TB requires specialized diagnostic and treatment capacity.

10. How does this opportunity relate to PEPFAR?

The opportunity is described as a targeted PEPFAR-supported effort intended to preserve and reinforce high-impact HIV and TB clinical capacity in Haiti, specifically at INLR and IMIS in Port-au-Prince.

11. What is meant by the amendment being "informational only"?

The text provided reflects an amendment that is informational only, meaning it is intended to add or clarify language in the notice rather than reopen or change the competition in a way that would accept new applications.

12. Is CDC accepting new applications under this notice?

No. The notice states that CDC is not accepting new applications for award under this opportunity.

13. What did the amendment add or clarify?

The amendment is described as adding or clarifying language around HIV epidemic control under the section titled "Other National Public Health Priorities and Strategies."

14. What does "HIV epidemic control" mean in the context provided?

In practical terms, the updated framing signals alignment with PEPFAR priorities aimed at driving toward epidemic control by improving diagnosis coverage, treatment coverage, and viral suppression, and focusing resources and strategies to reduce new infections and HIV-related mortality.

15. What is the activity category and funding type?

The opportunity is categorized as discretionary funding and falls under the Health activity category.

16. What is the CFDA number associated with this opportunity?

The opportunity is associated with CFDA number 93.067.

17. What is the award ceiling listed for this opportunity?

The listing indicates an award ceiling of $3,000,000.

18. How many awards were expected?

The listing indicates an expectation of one award, suggesting a single primary recipient would have been selected to implement or coordinate the work in close collaboration with CDC and local partners.

19. When was the opportunity created and when was it originally due?

The opportunity was created on December 4, 2015, and the original closing date was February 4, 2016.

20. Who is eligible to apply, based on the eligibility description?

The eligibility described is very broad and includes domestic and non-domestic entities. Eligible applicant types listed include:

  • Government entities (state, county, city/township, special district, regional organizations, and U.S. territories)
  • Educational institutions (public and private institutions of higher education)
  • Minority-serving institutions (including HBCUs, Hispanic-serving institutions, and Alaska Native and Native Hawaiian-serving institutions)
  • Tribal governments and tribally designated organizations
  • Public housing authorities
  • Nonprofits with or without 501(c)(3) status
  • Individuals
  • For-profit organizations (including small businesses)
  • Non-U.S. entities

21. What additional organizations are explicitly mentioned under "Other" eligibility language?

The "Other" eligibility language explicitly mentions ministries of health, tribal epidemiology centers, urban Indian health organizations, research institutions conducting activities deemed non-research, colleges and universities, community-based and faith-based organizations, hospitals, and small, minority-, and women-owned businesses, along with a catch-all statement indicating all other eligible organizations.

22. Does the description indicate whether the work is research or non-research?

The eligibility text references "research institutions conducting activities deemed non-research," which indicates that research institutions could be eligible when the activities they propose are considered non-research in this context.

23. What are the main service delivery goals described for HIV testing and linkage to care?

The description highlights high-quality HIV testing and counseling (HTC) so more people can learn their HIV status promptly and be linked to care.

24. What are the main service delivery goals described for PMTCT?

The opportunity emphasizes prevention of mother-to-child transmission (PMTCT) to reduce new pediatric HIV infections by ensuring pregnant and breastfeeding individuals have access to testing, antiretroviral therapy, and follow-up services.

25. What are the main components mentioned for adult and pediatric HIV treatment services?

The description generally characterizes these services as maintaining clinical capacity for antiretroviral initiation and management, routine monitoring, adherence support, and management of opportunistic infections, for both pediatric and adult patients.

26. Why is TB and MDR TB capacity integrated into this HIV-focused effort?

The description emphasizes TB and MDR TB because TB is a leading cause of illness and death among people living with HIV, and MDR TB requires specialized diagnostic and treatment capacity. The program integrates these priorities by reinforcing TB/MDR TB prevention, diagnosis, and treatment alongside HIV services.

27. What does the description suggest about CDC's role during implementation?

Because the award is a cooperative agreement, the description indicates CDC would typically remain substantially involved through program direction, monitoring, and technical support as the work is carried out.

28. Is this opportunity currently open for competition?

No. The notice states CDC is not accepting new applications, and the amendment does not reopen the competition.

Browse more opportunities from the same agency: Centers for Disease Control - CGH

Browse more opportunities from the same category: Health

Next opportunity: Leveraging Local Community Partnerships to Combat Nature Crimes

Previous opportunity: Spatially Scalable Integrated Tick Vector/Rodent Reservoir Management to Reduce Human Risk of Exposure to Ixodes scapularis Ticks Infected with Lyme Disease Spirochetes

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA GH16 1680

 

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA GH16 1680) also looked into and applied for these:

Funding Opportunity
Strengthening Health Management Information Systems, Data Use and Data Quality in the Republic of Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1674

Funding Number: CDC RFA GH16 1674
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $1,500,000
Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE): Study to Explore Early Development (SEED) 3 Apply for RFA DD 16 001

Funding Number: RFA DD 16 001
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $800,000
Technical Assistance to Host Country Public Health Institutions in Tanzania to Lead HIV Response and Develop and Sustain Systems Required to Achieve and Sustain HIV Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1650

Funding Number: CDC RFA GH16 1650
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $1,159,375
Building Capacity to Deliver High Quality HIV Prevention, Care and Treatment Services for Key Populations and People Living with HIV in the Caribbean Region under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1607

Funding Number: CDC RFA GH16 1607
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $1,036,000
HIV Surveillance for Epidemic Control in Malawi under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1629

Funding Number: CDC RFA GH16 1629
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $700,000
Assisting the Ministry of Health and Social Services (MOHSS) in Providing Critical Human Resources for Health to Achieve HIV Epidemic Control in Namibia under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1640

Funding Number: CDC RFA GH16 1640
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $8,867,471
Prevention of Healthcare-Associated Tuberculosis Infection in Zimbabwe under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1673

Funding Number: CDC RFA GH16 1673
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $1,500,000
Strengthening the HIV Services Quality Improvement and Quality Management Systems of the Ethiopian Federal Ministry of Health, Regional Health Bureaus, and Public Health Facilities under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1614

Funding Number: CDC RFA GH16 1614
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $1,000,000
Supporting the Implementation and Expansion of High Quality, Sustainable and Comprehensive HIV Prevention, Care and Treatment Programs in the Central Region and Laikipia County of the Republic of Kenya under the President’s Emergency Plan for A Apply for CDC RFA GH16 1700

Funding Number: CDC RFA GH16 1700
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $10,000,000
Supporting Implementation of Comprehensive HIV Prevention, Care and Treatment Programs in Bomu Hospital Affiliated Sites, Coptic Hospitals, and Faith-Based Sites in the Eastern Slums of Nairobi, Kenya under the President’s Emergency Plan for AI Apply for CDC RFA GH16 1690

Funding Number: CDC RFA GH16 1690
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $18,500,000
Increasing Access to and Availability of Sustainable, High Quality, Comprehensive Health and Structural Interventions among Key Populations and Priority Populations in Nairobi, Central, and Eastern Regions of the Republic of Kenya under the President Apply for CDC RFA GH16 1717

Funding Number: CDC RFA GH16 1717
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $10,000,000
Increasing Access to and Availability of Sustainable, High Quality, Comprehensive Health and Structural Interventions among Key Populations and Priority Populations in the Western and Rift Valley Regions of the Republic of Kenya under the President&# Apply for CDC RFA GH16 1716

Funding Number: CDC RFA GH16 1716
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $14,000,000
PPHF 2016 – Immunization - Immunization and Vaccines for Children Program – Financed in Part by 2016 Prevention and Public Health Funds Apply for CDC RFA IP13 130104PPHF16

Funding Number: CDC RFA IP13 130104PPHF16
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
National Syndromic Surveillance Program Community of Practice Apply for CDC RFA OE16 1601

Funding Number: CDC RFA OE16 1601
Agency: Centers for Disease Control - CSELS
Category: Health
Funding Amount: $400,000
Core State Violence and Injury Prevention Program (Core SVIPP) Apply for CDC RFA CE16 1602

Funding Number: CDC RFA CE16 1602
Agency: Centers for Disease Control - NCIPC
Category: Health
Funding Amount: $475,000
Building Sustainable Laboratory Quality Systems in Cote d’Ivoire under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1612

Funding Number: CDC RFA GH16 1612
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $3,000,000
Strengthening the Strategic Information Capacity of the Ministry of Health (MOH) in Support of HIV/AIDS Prevention, Care and Treatment Activities in the Democratic Republic of Congo under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1613

Funding Number: CDC RFA GH16 1613
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $1,000,000
Advanced Education Nursing Traineeship (AENT) Program Apply for HRSA 16 071

Funding Number: HRSA 16 071
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Johnston County Osteoarthritis Project: Arthritis, Disability, and Other Chronic Diseases Apply for RFA DP 16 003

Funding Number: RFA DP 16 003
Agency: Centers for Disease Control and Prevention - ERA
Category: Health
Funding Amount: $1,500,000
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH16 1643

Funding Number: CDC RFA GH16 1643
Agency: Centers for Disease Control - CGH
Category: Health
Funding Amount: $170,000,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH16 1680", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: